5 Key Takeaways

• 1

  Uveitis is a major cause of vision loss, contributing to 15% of blindness in developed countries.

• 2

  Current treatments like corticosteroids have limitations, especially in refractory uveitis cases.

• 3

  The cGAS–STING pathway is identified as a potential new target for uveitis therapy.

• 4

  Research using a mouse model showed that cGAS activation leads to increased ocular inflammation.

• 5

  Targeting cGAS could provide a novel treatment strategy for patients unresponsive to existing therapies.